Yao L - Search Results

1

High expression of metabolic enzyme PFKFB4 is associated with poor prognosis of operable breast cancer.

Yao L, Wang L, Cao ZG, Hu X, Shao ZM. Yao L, et al. Cancer Cell Int. 2019 Jun 18;19:165. doi: 10.1186/s12935-019-0882-2. eCollection 2019. Cancer Cell Int. 2019. PMID: 31244553 Free PMC article.

2

ID2 predicts poor prognosis in breast cancer, especially in triple-negative breast cancer, and inhibits E-cadherin expression.

Li K, Yao L, Chen L, Cao ZG, Yu SJ, Kuang XY, Hu X, Shao ZM. Li K, et al. Among authors: yao l. Onco Targets Ther. 2014 Jun 18;7:1083-94. doi: 10.2147/OTT.S64759. eCollection 2014. Onco Targets Ther. 2014. PMID: 24971018 Free PMC article.

3

High Levels of Nucleolar Spindle-Associated Protein and Reduced Levels of BRCA1 Expression Predict Poor Prognosis in Triple-Negative Breast Cancer.

Chen L, Yang L, Qiao F, Hu X, Li S, Yao L, Yang XL, Shao ZM. Chen L, et al. Among authors: yao l. PLoS One. 2015 Oct 20;10(10):e0140572. doi: 10.1371/journal.pone.0140572. eCollection 2015. PLoS One. 2015. PMID: 26485712 Free PMC article.

4

Elevated expression of RNA methyltransferase BCDIN3D predicts poor prognosis in breast cancer.

Yao L, Chi Y, Hu X, Li S, Qiao F, Wu J, Shao ZM. Yao L, et al. Oncotarget. 2016 Aug 16;7(33):53895-53902. doi: 10.18632/oncotarget.9656. Oncotarget. 2016. PMID: 27259993 Free PMC article.

5

High expression of microRNA-454 is associated with poor prognosis in triple-negative breast cancer.

Cao ZG, Li JJ, Yao L, Huang YN, Liu YR, Hu X, Song CG, Shao ZM. Cao ZG, et al. Among authors: yao l. Oncotarget. 2016 Oct 4;7(40):64900-64909. doi: 10.18632/oncotarget.11764. Oncotarget. 2016. PMID: 27588500 Free PMC article.

6

MicroRNA-493 is a prognostic factor in triple-negative breast cancer.

Yao L, Liu Y, Cao Z, Li J, Huang Y, Hu X, Shao Z. Yao L, et al. Cancer Sci. 2018 Jul;109(7):2294-2301. doi: 10.1111/cas.13644. Epub 2018 Jun 27. Cancer Sci. 2018. PMID: 29777630 Free PMC article.

7

Cytidine Deaminase Axis Modulated by miR-484 Differentially Regulates Cell Proliferation and Chemoresistance in Breast Cancer.

Ye FG, Song CG, Cao ZG, Xia C, Chen DN, Chen L, Li S, Qiao F, Ling H, Yao L, Hu X, Shao ZM. Ye FG, et al. Among authors: yao l. Cancer Res. 2015 Apr 1;75(7):1504-15. doi: 10.1158/0008-5472.CAN-14-2341. Epub 2015 Feb 2. Cancer Res. 2015. PMID: 25643696

8

Expression of autophagy-related proteins ATG5 and FIP200 predicts favorable disease-free survival in patients with breast cancer.

Wang L, Yao L, Zheng YZ, Xu Q, Liu XP, Hu X, Wang P, Shao ZM. Wang L, et al. Among authors: yao l. Biochem Biophys Res Commun. 2015 Mar 20;458(4):816-22. doi: 10.1016/j.bbrc.2015.02.037. Epub 2015 Feb 14. Biochem Biophys Res Commun. 2015. PMID: 25689718

9

Phase II trial of weekly nab-paclitaxel and carboplatin treatment with or without trastuzumab as nonanthracycline neoadjuvant chemotherapy for locally advanced breast cancer.

Huang L, Chen S, Yao L, Liu G, Wu J, Shao Z. Huang L, et al. Among authors: yao l. Int J Nanomedicine. 2015 Mar 11;10:1969-75. doi: 10.2147/IJN.S77000. eCollection 2015. Int J Nanomedicine. 2015. PMID: 25792830 Free PMC article. Clinical Trial.

10

Genetic evaluation of BRCA1 associated a complex genes with triple-negative breast cancer susceptibility in Chinese women.

Ling H, Li S, Wu Y, Zheng YZ, Qiao F, Yao L, Cao ZG, Ye FG, Wu J, Hu X, Wang B, Shao ZM. Ling H, et al. Among authors: yao l. Oncotarget. 2016 Mar 1;7(9):9759-72. doi: 10.18632/oncotarget.7112. Oncotarget. 2016. PMID: 26848770 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,862 results

Search Page

Filters